Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
The Journal of Obstetrics and Gynecology of India
Erschienen in: The Journal of Obstetrics and Gynecology of India 4/2019

10.04.2019 | Review Article

Sex Hormones and Cognition: Where Do We Stand?

verfasst von: Satish V. Khadilkar, MD, DM, DNBE, FIAN, FICP, FAMS, FRCP (London), Varsha A. Patil, MD, DM

Erschienen in: The Journal of Obstetrics and Gynecology of India | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Hypothalamic–pituitary–gonadal axis regulates the reproductive system. The overall health and wellbeing of a woman is subject to fluctuations in the sex hormones throughout her lifespan. Menopause, either natural or surgically induced, is often associated with cognitive complaints, especially memory disturbances. Sex hormones, besides affecting the reproductive function, affect the central nervous system in many ways. Here, we aim to review the role of sex hormones in cognition and the current evidence on use of or against menopausal hormonal therapy as a cognition enhancer in women with cognitive disturbances, including those with Alzheimer’s disease.
Literatur
1.
Gourie-Devi M. Epidemiology of neurological disorders in India: review of background, prevalence and incidence of epilepsy, stroke, Parkinson’s disease and tremors. Neurol India. 2014;62(6):588–98.PubMedCrossRef
2.
Banerjee TK, Dutta S, Das S, et al. Epidemiology of dementia and its burden in the city of Kolkata, India. Int J Geriatr Psychiatry. 2017;32(6):605–14.PubMedCrossRef
3.
Dubey M, Ram U, Ram F. Threshold levels of infant and under-five mortality for crossover between life expectancies at ages zero, one and five in India: a decomposition analysis. PLoS ONE. 2015;10(12):e0143764.PubMedPubMedCentralCrossRef
4.
Alzheimer’s NM. Disease: prototype of cognitive deterioration, valuable lessons to understand human cognition. Neurol Clin. 2016;34(1):69–131.CrossRef
5.
American Psychiatric Association. DSM-5: diagnostic and statistical manual of mental disorders, vol. 5. Washington, DC: American Psychiatric Association; 2013.CrossRef
6.
Podcasy JL, Epperson CN. Considering sex and gender in Alzheimer disease and other dementias. Dialogues Clin Neurosci. 2016;18(4):437–46.PubMedPubMedCentral
7.
GBD. Dementia collaborators global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2016;18(1):88–106.
8.
Hersi M, Irvine B, Gupta P, et al. Risk factors associated with the onset and progression of Alzheimer’s disease: a systematic review of the evidence. Neurotoxicology. 2017;2017(61):143–87.CrossRef
9.
Hickman RA, Faustin A, Alzheimer WT. disease and its growing epidemic: risk factors, biomarkers, and the urgent need for therapeutics. Neurol Clin. 2016;34(4):941–53.PubMedPubMedCentralCrossRef
10.
Gliebus GP. Memory dysfunction continuum (MinneapMinn). Behav Neurol Psychiatry. 2018;24(3):727–44.
11.
12.
13.
Hamson DK, Roes MM, Galea LA. Sex hormones and cognition: neuroendocrine influences on memory and learning. Compr Physiol. 2016;6(3):1295–337.PubMedCrossRef
14.
Palm R, Ayala-Fontanez N, Garcia Y, et al. Neuroendocrinology-based therapy for Alzheimer’s disease. BioFactors. 2012;38(2):123–32.PubMedCrossRef
15.
Vadakkadath Meethal S, Atwood CS. The role of hypothalamic-pituitary-gonadal hormones in the normal structure and functioning of the brain. Cell Mol Life Sci. 2005;62(3):257–70.PubMedCrossRef
16.
Gurvich C, Hoy K, Thomas N, et al. Sex differences and the influence of sex hormones on cognition through adulthood and the aging process. Brain Sci. 2018;8(9):E163.PubMedCrossRef
17.
Vogel JJ, Bowers CA, Vogel DS. Cerebral lateralization of spatial abilities: a meta-analysis. Brain Cogn. 2003;52(2):197–204.PubMedCrossRef
18.
Yaffe K, Lui LY, Zmuda J, et al. Sex hormones and cognitive function in older men. J Am Geriatr Soc. 2002;50(4):707–12.PubMedCrossRef
19.
LeBlanc ES, Wang PY, Janowsky JS, et al. Osteoporotic fractures in men (MrOS) research group. Association between sex steroids and cognition in elderly men. Clin Endocrinol (Oxf). 2010;72(3):393–403.CrossRef
20.
Roldán-Tapia MD, Cánovas R, León I, et al. Cognitive vulnerability in aging may be modulated by education and reserve in healthy people. Front Aging Neurosci. 2017;9:340.PubMedPubMedCentralCrossRef
21.
Mitchell ES, Woods NF. Cognitive symptoms during the menopausal transition and early postmenopause. Climacteric. 2011;14(2):252–61.PubMedCrossRef
22.
Weber MT, Rubin LH, Maki PM. Cognition in perimenopause: the effect of transition stage. Menopause. 2013;20(5):511–7.PubMed
23.
Resnick SM, Matsumoto AM, Stephens-Shields AJ, et al. Testosterone treatment and cognitive function in older men with low testosterone and age-associated memory impairment. JAMA. 2017;317(7):717–27.PubMedPubMedCentralCrossRef
24.
Weber MT, Maki PM, McDermott MP. Cognition and mood in perimenopause: a systematic review and meta-analysis. J Steroid Biochem Mol Biol. 2014;2014(142):90–8.CrossRef
25.
Epperson CN, Sammel MD, Freeman EW. Menopause effects on verbal memory: findings from a longitudinal community cohort. J Clin Endocrinol Metab. 2013;98:3829–38.PubMedPubMedCentralCrossRef
26.
27.
28.
Frankfurt M, Gould E, Woolley CS, et al. Gonadal steroids modify dendritic spine density in ventromedial hypothalamic neurons: a Golgi study in the adult rat. Neuroendocrinology. 1990;51(5):530–5.PubMedCrossRef
29.
Tuscher JJ, Luine V, Frankfurt M, et al. Estradiol-mediated spine changes in the dorsal hippocampus and medial prefrontal cortex of ovariectomized female mice depend on ERK and mTOR activation in the dorsal hippocampus. J Neurosci. 2016;36(5):1483–9.PubMedPubMedCentralCrossRef
30.
Luine V. Estradiol: mediator of memories, spine density and cognitive resilience to stress in female rodents. J Steroid Biochem Mol Biol. 2016;2016(160):189–95.CrossRef
31.
32.
Engler-Chiurazzi EB, Singh M, Simpkins JW. From the 90′s to now: a brief historical perspective on more than two decades of estrogen neuroprotection. Brain Res. 2016;1633:96–100.PubMedCrossRef
33.
34.
Goodman Y, Bruce AJ, Cheng B, et al. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J Neurochem. 1996;66(5):1836–44.PubMedCrossRef
35.
Foy MR, Akopian G, Thompson RF. Progesterone regulation of synaptic transmission and plasticity in rodent hippocampus. Learn Mem. 2008;15(11):820–2.PubMedPubMedCentralCrossRef
36.
Prakapenka AV, Hiroi R, Quihuis AM, et al. Contrasting effects of individual versus combined estrogen and progestogen regimens as working memory load increases in middle-aged ovariectomized rats: one plus one does not equal two. Neurobiol Aging. 2018;2018(64):1–14.CrossRef
37.
Koebele SV, Bimonte-Nelson HA. The endocrine-brain-aging triad where many paths meet: female reproductive hormone changes at midlife and their influence on circuits important for learning and memory. Exp Gerontol. 2017;2017(94):14–23.CrossRef
38.
Taylor GT, Manzella FM, Huffman J, et al. Cognition in female rats after blocking conversion of androgens to estrogens. Horm Behav. 2017;2017(90):84–9.CrossRef
39.
Hara Y, Park CS, Janssen WG, et al. Synaptic correlates of memory and menopause in the hippocampal dentate gyrus in rhesus monkeys. Neurobiol Aging. 2012;33(2):421.e17–28.CrossRef
40.
Kurita K, Henderson VW, Gatz M, et al. Association of bilateral oophorectomy with cognitive function in healthy, postmenopausal women. Fertil Steril. 2016;106(3):749–56.PubMedPubMedCentralCrossRef
41.
Amtul Z, Wang L, Westaway D, et al. Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer’s disease. Neuroscience. 2010;169(2):781–6.PubMedCrossRef
42.
Coker LH, Espeland MA, Rapp SR, et al. Postmenopausal hormone therapy and cognitive outcomes: the Women’s Health Initiative Memory Study (WHIMS). J Steroid Biochem Mol Biol. 2010;118(4–5):304–10.PubMedCrossRef
43.
Resnick SM, Coker LH, Maki PM, et al. The Women’s Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline. Clin Tr. 2004;1:440–50.CrossRef
44.
Anderson GL, Manson J, Wallace R, et al. Implementation of the Women’s Health Initiative study design. Ann Epidemiol. 2003;13:S5–17.PubMedCrossRef
45.
46.
Lobo RA. Where are we 10 years after the Women’s health initiative? J Clin Endocrinol Metab. 2013;98(5):1771–80.PubMedCrossRef
47.
Imtiaz B, Tuppurainen M, Rikkonen T, et al. Postmenopausal hormone therapy and Alzheimer disease: a prospective cohort study. Neurology. 2017;88(11):1062–8.PubMedPubMedCentralCrossRef
48.
Maki PM, Henderson VW. Hormone therapy, dementia, and cognition: the Women’s Health Initiative 10 years on. Climacteric. 2012;15(3):256–62.PubMedPubMedCentralCrossRef
49.
Resnick SM, Espeland MA, Jaramillo SA, et al. Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI study. Neurology. 2009;72(2):135–42.PubMedPubMedCentralCrossRef
50.
Laws KR, Irvine K, Gale TM. Sex differences in Alzheimer’s disease. Curr Opin Psychiatry. 2018;31(2):133–9.PubMedCrossRef
51.
52.
Tschanz JT, Norton MC, Zandi PP, et al. The cache county study on memory in aging: factors affecting risk of Alzheimer’s disease and its progression after onset. Int Rev Psychiatry. 2013;25(6):673–85.PubMedPubMedCentralCrossRef
53.
Imtiaz B, TolppanenAM SA, Soininen H, et al. Estradiol and cognition in the cardiovascular risk factors, aging and dementia (CAIDE) cohort study. J Alzheimers Dis. 2017;56(2):453–8.PubMedCrossRef
54.
Marder K, Tang MX, Alfaro B, et al. Postmenopausal estrogen use and Parkinson’s disease with and without dementia. Neurology. 1998;50(4):1141–3.PubMedCrossRef
55.
56.
Rocca WA, Bower JH, Maraganore DM, et al. Melton LJ 3rd Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology. 2007;69(11):1074–83.PubMedCrossRef
57.
Phung TK, Waltoft BL, Laursen TM, et al. Hysterectomy, oophorectomy and risk of dementia: a nationwide historical cohort study. Dement Geriatr Cogn Disord. 2010;30(1):43–50.PubMedCrossRef
58.
Bove R, Secor E, Chibnik LB, et al. Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology. 2014;82(3):222–9.PubMedPubMedCentralCrossRef
59.
Espeland MA, Rapp SR, Manson JE, et al. WHIMSY and WHIMS-ECHO study groups long-term effects on cognitive trajectories of postmenopausal hormone therapy in two age groups. J Gerontol A Biol Sci Med Sci. 2017;72(6):838–45.PubMed
60.
Gleason CE, Dowling NM, Wharton W, et al. Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized, controlled KEEPS-cognitive and affective study. PLoS Med. 2015;12(6):e1001833.PubMedPubMedCentralCrossRef
61.
Henderson VW, St John JA, Hodis HN, et al. Cognitive effects of estradiol after menopause: a randomized trial of the timing hypothesis. Neurology. 2016;87(7):699–708.PubMedPubMedCentralCrossRef
62.
Mielke MM, Vemuri P, Rocca WA. Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences. Clin Epidemiol. 2014;2014(6):37–48.CrossRef
63.
Whitmer RA, Quesenberry CP, Zhou J, et al. Timing of hormone therapy and dementia: the critical window theory revisited. Ann Neurol. 2011;69(1):163–9.PubMedCrossRef
64.
Cobin RH, Goodman NF. AACE reproductive endocrinology scientific committee. American association of clinical endocrinologists and American college of endocrinology position statement on menopause-2017 update. Endocr Pract. 2017;23(7):869–80.PubMedCrossRef
65.
Maki PM. Minireview: effects of different HT formulations on cognition. Endocrinology. 2012;153(8):3564–70.PubMedCrossRef
66.
Davis SR, Wahlin-Jacobsen S. Testosterone in women–the clinical significance. Lancet Diabetes Endocrinol. 2015;3(12):980–92.PubMedCrossRef
67.
Henderson VW, Ala T, Sainani KL, et al. Raloxifene for women with Alzheimer disease: a randomized controlled pilot trial. Neurology. 2015;85(22):1937–44.PubMedPubMedCentralCrossRef
68.
Yang ZD, Yu J, Zhang Q. Effects of raloxifene on cognition, mental health, sleep and sexual function in menopausal women: a systematic review of randomized controlled trials. Maturitas. 2013;75(4):341–8.PubMedCrossRef
69.
The NAMS. Hormone therapy position statement advisory panel. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. 2017;24(7):728–53.CrossRef
70.
Pines A. Alzheimer’s disease, menopause and the impact of the estrogenic environment. Climacteric. 2016;19(5):430–2.PubMedCrossRef
Metadaten
Titel
Sex Hormones and Cognition: Where Do We Stand?
verfasst von
Satish V. Khadilkar, MD, DM, DNBE, FIAN, FICP, FAMS, FRCP (London)
Varsha A. Patil, MD, DM
Publikationsdatum
10.04.2019
Verlag
Springer India
Erschienen in
The Journal of Obstetrics and Gynecology of India / Ausgabe 4/2019
Print ISSN: 0971-9202
Elektronische ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-019-01223-5

Weitere Artikel der Ausgabe 4/2019

The Journal of Obstetrics and Gynecology of India 4/2019 Zur Ausgabe

Original Article

Evaluate the Feasibility of Surgical Transversus Abdominis Plane Block for Postoperative Analgesia After Cesarean Section

Original Article

Safety and Efficacy of Intra-caesarean IUCD: A Prospective Study at a Tertiary Care Centre

Original Article

Posterior Reversible Encephalopathy Syndrome (PRES): Evolving the Mystery of Eclampsia!

Original Article

Methylenetetrahydrofolate Reductase Enzyme Level and Antioxidant Activity in Women with Gestational Hypertension and Pre-eclampsia in Lagos, Nigeria

Original Article

Role of Chromohysteroscopy in Evaluation of Endometrial Pathology Using Methylene Blue Dye

Letter to the Editor

Comment on the Editorial “The Plague of Plagiarism: Prevention and Cure!!!”

Neu im Fachgebiet Gynäkologie und Geburtshilfe

17.04.2024 | Postoperative nausea and vomiting | Nachrichten

Hochrisiko-Eingriffe für postoperative Übelkeit

17.04.2024 | Mammakarzinom | Nachrichten

Adjuvante Brustkrebstherapie: Doppelt hält besser

16.04.2024 | Maligne primäre ZNS-Tumoren | Nachrichten

Manche Gestagene können das Risiko für Meningeome erhöhen

16.04.2024 | Stillen, Säuglingsnahrung, Beikost | Nachrichten

Stillende Frauen haben geringeres kardiovaskuläres Risiko
weitere anzeigen

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen